Sabaa International Company for Pharmaceutical and Chemical Industry reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EGP 3.21 million compared to EGP 7.81 million a year ago. Net loss was EGP 1.46 million compared to EGP 1.33 million a year ago.
For the nine months, sales was EGP 8.43 million compared to EGP 13.91 million a year ago. Net loss was EGP 3.88 million compared to net income of EGP 0.488979 million a year ago. Basic loss per share from continuing operations was EGP 0.016 compared to basic earnings per share from continuing operations of EGP 0.002 a year ago.